Introduction

Vibrio vulnificus is a Gram-negative bacterium that inhabits estuarine environments. The bacteria prefer a growth temperature of 22–30 °C and a salinity of 15–25 ppt, and they are therefore more abundant in waters from the warmer Gulf Coast than the cooler New England and Pacific coasts1. V. vulnificus-related gastroenteritis infections are commonly known to be caused by the consumption of raw or undercooked seafood such as oysters2. Filter feeders such as oysters, clams, mussels, and scallops concentrate bacteria that are associated with plankton, thereby acting as passive carriers to allow the entry of Vibrios into the food chain and infecting humans3. Strains of V. vulnificus can survive in oysters under cold storage and certain encapsulated strains can survive the phagocytic effects of hemocytes.

Mollusks are an important ecological niche for Vibrios. Since the animals generally have an open circulatory system, the bacteria encounter hemolymph components during the filter-feeding process. Such components include hemocyanin, which is used for oxygen transport4. Hemocyanin’s ability to bind oxygen depends on environmental conditions, and oxygen binding is increased by allosteric binding of naturally occurring metabolites such as urate, which accumulates during hypoxia5. Urate is the product of xanthine oxidoreductase, which participates in purine salvage and degradation by converting hypoxanthine to xanthine and xanthine to urate; urate accumulates during hypoxia because degradation of urate is an oxygen-dependent process6,7. Accordingly, xanthine and urate would also be among the hemolymph components encountered by Vibrios, particularly when the mollusks experience hypoxia. Marine ecosystems – and resident sessile species such as mollusks – frequently experience hypoxia8. Under hypoxia and elevated CO2 levels (hypercapnia), oysters also have a decreased ability to inactivate bacteria within their tissues compared to oysters maintained under normoxic conditions. As a result, oysters that experience hypoxia and hypercapnia retain a larger number of culturable bacteria9.

The generation of reactive oxygen species (ROS) by a host (including mollusk) in response to invading bacteria is a first attempt at killing the invader; ROS will react with bacterial macromolecules to cause injury or death unless the ROS get inactivated by bacterial antioxidant responses10. While host cytoplasmic NADPH oxidase is a primary producer of ROS, xanthine oxidoreductase can also participate in ROS production. Under normal conditions, the enzyme exists as xanthine dehydrogenase (XDH), which uses NAD+ as a cofactor to form NADPH during the enzymatic reactions to form xanthine and urate. This is the version of the enzyme predominantly detected in mollusks, arguing against a role for molluscan xanthine oxidoreductase in ROS production11,12. However, the mammalian XDH can be converted to xanthine oxidase (XO), which uses molecular oxygen as an electron acceptor instead of NAD+, thereby generating the ROS superoxide radical (O2.−) and hydrogen peroxide during the production of xanthine and urate13. As a result, bacterial infection in mammals may be associated with increased levels of these purines; for example, infection with enteropathogenic Escherichia coli resulted in intestinal accumulation of urate in a rabbit model of infection14. Furthermore, xanthine oxidoreductase can also use nitrate as substrate to form nitric oxide (NO) during hypoxic conditions15. Like ROS, NO and reactive nitrogen species derived from NO target cellular macromolecules to cause cell death unless detoxified by the bacterial cell.

Members of the multiple antibiotic resistance regulator (MarR) protein family are important for bacterial responses to environmental change16. MarR proteins are often autoregulatory and they respond to changing environmental cues such as small molecule ligands, oxidants, or pH, the result of which is a conformational change in the protein that alters (usually abrogates) DNA binding and changes expression of target genes. The genes encoding MarR family proteins are frequently oriented divergent to genes under their regulatory control, and binding sites for the transcription factor (usually 16–18 bp palindromes) are located in the intergenic region. One example is PecS, first characterized in the plant pathogen Dickeya dadantii17; the pecS gene is divergently oriented to pecM, which encodes a transporter responsible for efflux of the antioxidant indigoidine. Both genes are repressed by PecS binding to the pecS-pecM intergenic region. D. dadantii pecS knockout strains showed an upregulation of numerous virulence genes, including genes encoding pectinases and indigoidine biosynthetic genes17,18. While the inducing signal for D. dadantii PecS remains unknown, PecS proteins from Agrobacterium fabrum, Streptomyces coelicolor, Klebsiella pneumoniae, and Pectobacterium atrosepticum have been shown to bind urate. As a result of urate binding to PecS, DNA binding is attenuated and target genes are upregulated19,20,21,22,23. The accumulation of urate in mammalian and plant tissues during infection rationalizes why bacteria may use this purine metabolite as a signal for induction of virulence-associated genes14,24. For example, the urate-responsive transcription factor MftR from Burkholderia thailandensis controls numerous virulence-associated genes that are differentially expressed on addition of urate25. Divergent pecS-pecM gene pairs are only encoded by select bacterial species, including members of the gamma-proteobacterial families Enterobacteriaceae and Vibrionaceae23.

We show here that duplications of pecS-pecM genes are common in Vibrios. In V. vulnificus, which harbors a single pecS-pecM locus, PecS binds not only pecS-pecM intergenic DNA, a result of which is attenuated gene expression. It also controls activity of the promoter driving expression of nitric oxide dioxygenase, an enzyme that converts nitric oxide to nitrate to prevent nitrosative stress. Properties of V. vulnificus PecS are consistent with control of gene expression under conditions of host-mediated production of purine metabolites, such as molluscan hypoxia or production of ROS in mammalian hosts.

Results

Conservation of the pecS-pecM locus in members of the family Vibrionaceae

The family Vibrionaceae comprises seven genera, Aliivibrio, Echinimonas, Enterovibrio, Grimontia, Photobacterium, Salinivibrio, and Vibrio, and numerous individual species have been identified within each genus. Many species are associated with marine environments, yet they are metabolically very diverse. A multilocus sequence analysis was performed in an effort to elucidate evolutionary history and genomic plasticity within the family Vibrionaceae; this analysis suggested the existence of 22 distinct clades plus two orphan clades and a superclade consisting of Salinivibrio, Grimontia and Enterovibrio spp26.

A BLASTp search of species representing the identified Vibrio clades using the V. vulnificus PecS (VvPecS) sequence was performed using the NCBI database. PecS homologs were confirmed by pair-wise alignment, and divergent genes were identified to assess the distribution of pecS-pecM gene pairs. VvPecS was previously shown to share significant homology to characterized PecS proteins from other bacterial species23; features distinguishing PecS proteins from canonical MarR homologs include a helical N-terminal extension (α1) containing a conserved tryptophan (Fig. S1)23. PecM proteins are characterized by two copies of the EamA protein domain (previously denoted DUF6) and are part of the drug/metabolite transporter (DMT) superfamily, as predicted by Pfam.

Divergent pecS-pecM genes were identified among many of the surveyed species, but not all. Specifically, divergent pecS-pecM genes were found in species belonging to the clades Mediterranei, Scopthalmi, and Vulnificus (to which V. vulnificus belongs) and in members of the Salinivibrio-Grimontia-Enterovibrio superclade (Table S1). Among other clades, only some species were found to encode pecS-pecM genes, and no pecS genes were identified in the clades Damselae, Halioticoli, Porteresiae, Rosenbergii, or in the orphan clade Tapetis. By contrast, some species belonging to the remaining clades were found to encode duplications of pecS-pecM gene pairs (Cholerae, Coralliilyticus, Harveyi, Nereis, Orientalis, and Proteolyticus). For some species belonging to the clades Cholerae, Harveyi, Mediterranei, Nigripulchritudo, and Phosphoreum, pecS-like genes were identified that were not divergently oriented to a pecM gene; in most cases, these species also encode pecS-pecM gene pairs.

An alignment of select PecS sequences, representing species that encode a single pecS-pecM gene pair (such as V. vulnificus) as well as species with pecS-pecM duplications (such as the coral pathogen V. coralliilyticus) or pecS encoded in a different genomic environment (such as the shrimp pathogen V. nigripulchritudo) verified conservation of residues previously reported to be important for folding and/or interaction with the ligand urate (Fig. S1). For species with pecS-pecM duplications, one PecS shares more similarity to VvPecS (Fig. 1; species identified in blue) whereas the second PecS is less conserved (Fig. 1; shown in black). A phylogenetic analysis of selected PecS sequences using the neighbor-joining method indicated that the more divergent PecS sequences cluster on a distinct branch.

Figure 1
figure 1

Duplication of PecS in some Vibrio species. Sequences of identified PecS proteins were aligned using MUSCLE and the phylogenetic tree was visualized with iTOL, using E. coli MarR as an outgroup. Sequences in blue representing the more conserved PecS sequences. Insert shows conservation of PecS binding sites in the intergenic region of conserved pecS-pecM gene pairs.

The intergenic pecS-pecM sequences corresponding to the more conserved PecS sequences were examined for the presence of PecS consensus binding sites23. All sequences were found to feature at least one, but more commonly two such cognate sites. Compiling 26 predicted sites from 14 intergenic sequences yielded the expected AT-rich consensus sequence characterized by the most significant conservation within the first 6 bp of each 9 bp half-site (Fig. 1; inset). Consistent with the presence of a consensus binding site, the sequence of the recognition helices (α5) is highly conserved (Fig. S1). The conservation of divergent pecS-pecM genes along with the cognate PecS binding site(s) strongly suggests conserved regulation of pecS/pecM expression by PecS, likely in response to similar signals.

VvPecS binds pecS-pecM intergenic DNA

VvPecS is expected to control the expression of pecS-pecM genes by binding the intergenic DNA (denoted iSM; Fig. 2A). To address this prediction, the gene encoding VvPecS (BJE04_RS19600) was cloned from V. vulnificus YJ016 genomic DNA (a generous gift from G. Pettis), and the protein was overexpressed in E. coli and purified to ~95% homogeneity (Fig. 2B). Upon treating VvPecS with glutaraldehyde (0.005% GTA), the protein monomer (Mw ~18.6 kDa) crosslinked to form a dimer of ~37 kDa. Multimeric forms of VvPecS also appeared at a higher glutaraldehyde concentration. To confirm the oligomeric state of the purified protein, size exclusion chromatography was performed; VvPecS eluted corresponding to the molecular weight of a dimer (~37 kDa; Fig. 2C). The protein also migrated as a single band on native PAGE (Fig. S2), which is consistent with a single species in solution. In the following description of DNA binding, all concentrations refer to the dimeric form of VvPecS.

Figure 2
figure 2

V. vulnificus PecS is a dimer. (A) Schematic representation of divergently oriented V. vulnificus pecS and pecM genes; VvPecS is expected to bind the intergenic DNA region iSM. (B) Coomassie Blue-stained 15% SDS-PAGE gel showing purified His6-tagged VvPecS (L1) and VvPecS incubated with 0.005% or 0.05% glutaraldehyde (GTA). Oligomeric states are indicated at the right. Mw markers (in kDa) at the left. (C) Size exclusion chromatography. Distribution coefficient as a function of Log10 Molecular weight of markers C, O, and A representing chymotrypsin (25 kDa), ovalbumin (44 kDa) and albumin (66 kDa), respectively. Elution of VvPecS marked with arrow. Uncropped version of gel in panel B shown in Fig. S7.

Binding to pecS-pecM intergenic DNA was assessed by the electrophoretic mobility assay (EMSA). Using the 200 bp iSM, which spans the region between pecS and pecM start codons, two distinct complexes were formed upon addition of lower concentrations of VvPecS (Fig. 3A), with additional complexes appearing with increasing VvPecS concentration; this suggests that the protein bound to multiple sites in the intergenic DNA. The percentage complex formation (total bound DNA) as a function of [PecS] was fitted to the Hill equation, which yielded an apparent macroscopic dissociation constant Kd = 0.3 ± 0.1 nM. Positive cooperativity of binding was indicated by a Hill coefficient nH = 2.7 ± 0.1, also suggesting at least three binding sites on the iSM DNA fragment. The binding reactions were performed at high ionic strength (0.5 M Tris, 100 mM NaCl), which would disfavor nonspecific binding. Specificity of VvPecS binding to iSM DNA was verified by the retention of VvPecS-iSM complex when the reactions were challenged with increasing concentration of pUC18 plasmid (Fig. S3A).

Figure 3
figure 3

VvPecS binds multiple sites in the pecS-pecM intergenic region. (A) EMSA gel showing VvPecS binding to 0.9 fmol of intergenic iSM DNA; concentrations of PecS are identified above each lane (in nM). Complexes (iSM:PecS) and free DNA (iSM) are identified at the right. (B) Percent complex as a function of Log10 VvPecS concentration. Error bars represents standard deviation (SD) of three replicates. Uncropped version of gel in panel A shown in Fig. S8.

VvPecS sites in the iSM DNA were mapped by DNase I footprinting. Using equivalent concentrations of DNA and VvPecS (each at 500 nM) a partial protection of two pseudo-palindromic sequences iSM-a and iSM-b was seen (Fig. 4B; orange line). At a stoichiometric excess of VvPecS:DNA of 2:1, complete protection of these sites was observed (Fig. 4A, lane 4, and 4B, blue line). Each protected site included the 18 bp consensus sequence and extended asymmetrically by about 8–10 bp (Fig. 4C). The iSM-a site is located 6 bp upstream of the pecM start codon, whereas iSM-b is 29 bp upstream of the pecS start codon, positions that would be consistent with repression of both genes by VvPecS. The two-fold excess of VvPecS required to protect iSM sites indicated that binding of two protein dimers occurs simultaneously and preferentially at the two palindromic sites. The intergenic region was entirely protected at 5000 nM of VvPecS (a 10-fold excess), with the region of protection extending well into the pecS coding region (Fig. 4B; red line). This is consistent with the positive cooperativity of binding seen in EMSA and with the inference that the iSM DNA can accommodate at least three PecS dimers. It also indicates that the multiple complexes observed in EMSA are due to VvPecS-DNA binding events as opposed to initial VvPecS-DNA complex formation followed by VvPecS-VvPecS binding.

Figure 4
figure 4

DNase I footprint of forward strand of pecS-pecM intergenic DNA. (A) Polyacrylamide sequencing gel: lane L1 – A + G ladder, L2 – undigested iSM fragment (500 nM); L3 – DNase I-digested iSM DNA; L4 to L6 – iSM DNA incubated with 1000 nM, 100 nM and 10 nM VvPecS, respectively, followed by DNase I digestion. (B) Densitometric traces of VvPecS protection of iSM (500 nM) DNA upon incubation with 0 nM (green), 500 nM (orange), 1,000 nM (blue) and 5,000 nM (red) VvPecS. C. Sequence of iSM intergenic sequence. The start codons of pecS and pecM are marked by solid black arrows. The pseudo-palindromic sequences are represented by orange bolded letters and protection by 1,000 nM PecS is underlined in blue. Reactions were performed under stoichiometric conditions ([DNA]  Kd). Data are representative of three experiments. Uncropped version of gel in panel A shown in Fig. S9.

Xanthine and urate are ligands for VvPecS

Several PecS homologs have been characterized and shown to bind urate, leading to attenuation of DNA binding19,20,21,22. Therefore, we tested whether increasing concentrations of intermediates in the purine degradation pathway such as urate and xanthine had an effect on VvPecS binding to iSM DNA (Fig. 5). The reactions contained 0.5 M Tris to negate the pH change that would otherwise be caused by the addition of ligands, which were dissolved in 0.4 M NaOH. Xanthine was found to attenuate PecS-iSM DNA binding with IC50 of 366 ± 31 µM (Ki = 60 ± 5 μM), which is ~4-fold better than urate for which IC50 was 1.5 ± 0.3 mM (Ki = 226 ± 29 μM) (Fig. 5A,B,D). However, even on addition of urate or xanthine up to 10 mM, the slowest-migrating VvPecS-iSM complex still remained, suggesting that neither ligand was able to disrupt a complex in which the DNA is saturated with protein; urate was modestly more efficient at disrupting this complex than xanthine (comparing basal plateaus in Fig. 5D). Guanosine and other intermediates in purine degradation, allantoin, hypoxanthine, GMP, and GTP did not affect DNA binding by VvPecS (Figs 5C and S4).

Figure 5
figure 5

Xanthine and urate are ligands for VvPecS. A-C. EMSA gels showing titrations of VvPecS (0.8 nM) and iSM DNA (0.9 fmol) with increasing concentration of ligands xanthine (A), urate (B), and guanosine (C). Free DNA (“D”) and protein-DNA complexes (“C”) identified at the right and ligand concentrations indicated above each lane. (D) Normalized percent complex formation as function of ligand concentration for urate and xanthine. Error bars represent standard deviation (SD) of three replicates. (E) Thermal stability of VvPecS. Fluorescence of SYPRO Orange bound to exposed hydrophobic regions of the protein as a function of temperature; fluorescence is normalized to the peak fluorescence. Unliganded VvPecS (black), and VvPecS incubated with urate (10 µM in yellow and 100 µM in orange), xanthine (10 µM in light green and 100 µM in dark green) and guanosine (100 µM in grey). The data are average relative fluorescence from triplicates. Uncropped versions of gels in panels A–C shown in Figs S10S12.

The interaction between ligands and VvPecS was further assessed with a thermal stability assay in which binding of the fluorescent dye SYPRO Orange to hydrophobic regions of the protein was monitored as a function of temperature. Unliganded VvPecS had a Tm of 45.0 ± 0.2 °C, indicating that the protein is stable at physiological temperatures. Both xanthine and urate very marginally stabilized VvPecS (Tm of 46.4 ± 0.2 °C and 46.0 ± 0.2 °C, respectively; Fig. 5E and Table S2). A more marked difference in the fluorescence profile that occurred on ligand (particularly xanthine) binding was the lower fluorescence at the beginning of the temperature scan, a change not observed on addition of guanosine; since fluorescence is a reporter for exposure of hydrophobic protein regions, this change may reflect burial of hydrophobic residues on ligand binding.

VvPecS represses gene expression in vivo

To examine the ability of VvPecS to repress gene activity in vivo, a reporter construct was generated in which the lacZ gene is under control of the pecS promoter (named prSZ). E. coli T7 Express was transformed with the reporter construct along with pET28b carrying the pecS gene or with empty pET28b. Compared to an empty pACYC184 negative control, significant β-galactosidase activity was observed for prSZ when cells were co-transformed with empty pET28b (Fig. 6, black bars); as expected, addition of IPTG had no effect on β-galactosidase activity (grey bars).

Figure 6
figure 6

In vivo lacZ reporter gene expression assay. E. coli T7 Express was transformed with pecS expression construct and/or reporter construct: (pr0) – empty pACYC184 and pET28b; (prSZ) – lacZ under control of pecS promoter and empty pET28b; (prSZ + pecS) – lacZ under control of pecS promoter and pecS expression construct. Black bars represent uninduced cultures (no IPTG) and grey bars induced cultures (80 μM IPTG to induce pecS expression). Where indicated, xanthine was included at 10 mM concentration. β-galactosidase activity is represented in Miller units. Error bars represent the standard deviation from three replicates. Asterisks represent statistically significant difference based on two-tailed Student’s t-test (*p < 0.05 and **p < 0.005).

When E. coli cells were co-transformed with prSZ and the pecS-expression vector (prSZ + pecS), β-galactosidase activity was significantly reduced, regardless of whether or not IPTG was added to induce pecS expression, although a further reduction in activity was recorded in induced cells. Compared to cells harboring prSZ only, the β-galactosidase levels were ~4.5- and 7-fold lower in uninduced and induced cells producing VvPecS, respectively. This indicates that VvPecS represses the expression of the IacZ reporter, and that leaky (uninduced) expression is sufficient for repression (Fig. 6).

Since xanthine was an efficient ligand for VvPecS in vitro (and less prone to precipitation compared to urate) we determined its ability to induce lacZ expression; upon cellular uptake, the metabolite xanthine would be expected to undergo conversion to urate or to enter the purine salvage pathway, ultimately to generate GTP. Presence of xanthine in the growth medium resulted in significantly increased β-galactosidase activity in uninduced cells (~3-fold higher relative to untreated cells; Fig. 6). In cells to which IPTG was added to induce pecS expression, a modest 1.6-fold increase in β-galactosidase activity was observed on addition of xanthine. This indicates that xanthine (and/or urate) can relieve the VvPecS-mediated repression of the lacZ reporter, except when PecS is overexpressed as a result of IPTG induction.

VvPecS binds the intergenic region between nsrR and nod genes

To identify other possible genes under VvPecS control, Patloc was used to search the V. vulnificus YJ016 genome using the perfectly palindromic VvPecS site 5′-TATCTTTATATTAAGATA-3′ as a query, allowing for five mismatches27. Sequences upstream of annotated genes in which the mismatches primarily occur within the last 3 bp of each half-site (the least-conserved part of the overall PecS consensus sequence; Fig. 1) were examined. Several potential sites within gene promoters were identified on both chromosomes I and II, including sites in the intergenic region between BJE04_RS14760 and BJE04_RS14765 encoding the transcription factor NsrR and a nitric oxide dioxygenase (NOD), respectively. NsrR encodes a nitric oxide sensitive response regulator, which upon NO-mediated damage to its iron-sulfur cluster no longer binds DNA. This leads to derepression of genes encoding proteins involved in nitric oxide detoxification, such as nod. Nitric oxide dioxygenase converts NO to nitrate in a reaction that requires oxygen28.

A single palindromic site 5′-TTTCTTGAT·TGAAAGATA-3′ was found 35 bp upstream of the start codon of the nsrR gene in the intergenic DNA (iNR) region of divergently oriented nsrR-nod genes (Fig. S5A). This site is also conserved in the intergenic region between V. parahaemolyticus nsrR and nod genes (VP2808 and VP2809; not shown). VvPecS bound the iNR fragment (Fig. S5B) with a Kd of 218 ± 38 nM (Fig. S5D), a considerably lower affinity compared to the Kd of VvPecS for iSM. Specificity of VvPecS-iNR binding was indicated by the retention of complex upon addition of an up to ~5,000-fold excess of nonspecific lambda DNA (48.5 Kbp) (Fig. S5C). In contrast, the complex gradually disappeared when titrated with up to ~90-fold excess of unlabeled iNR (Fig. S5C). This indicates that the binding of VvPecS to the single site in iNR is specific. The VvPecS-iNR complex was attenuated in the presence of xanthine and urate, with IC50 of 242 ± 69 µM (Ki = 73 ± 21 µM) and 744 ± 96 µM (Ki = 226 ± 29 µM), respectively (Fig. S6). The attenuation of VvPecS-iNR complex in the presence of ligands follows a similar trend as that of VvPecS-iSM, with xanthine and urate functioning as ligands.

VvPecS mediates repression of nod promoter activity in vivo

A reporter construct was generated in which lacZ is under control of the nod promoter (named prNZ) and β-galactosidase activity was measured in E. coli. In absence of the pecS expression vector, an ~9-fold lower β-galactosidase activity was measured for prNZ compared to prSZ, suggesting that the nod promoter is weaker than the pecS promoter in E. coli (Fig. 7A). Due to the lower levels of lacZ expression in the prNZ construct, uninduced conditions (leaky expression of pecS) were maintained for assessing the ability of VvPecS to repress nod promoter activity.

Figure 7
figure 7

VvPecS represses nod promoter activity in vivo. In vivo lacZ reporter gene assay in which E. coli T7 Express was transformed with pecS expression construct and/or reporter construct. β-galactosidase levels (in Miller units) in uninduced E. coli expression host harboring gene constructs: (pr0) – empty pACYC184 and pET28b; (prSZ) – lacZ under control of pecS promoter and empty pET28b; (prNZ) – lacZ under control of nod promoter and empty pET28b; (prNZ + pecS) – lacZ under control of nod promoter and pecS expression construct. (A) Comparison between prSZ and prNZ promoter activities in the absence of VvPecS (asterisks indicate p < 0.005). (B) Activity of prNZ in absence or presence of NONOate (25 μM). (C) Effects of VvPecS and xanthine on activity of prNZ. Asterisks indicate p < 0.005 compared to (prNZ) cells based on two-tailed Student’s t-test. Error bars represents standard deviation from three replicates.

Examination of the iNR sequence also revealed a possible binding site for E. coli NsrR29 that could interfere with the expression analysis. To test if there was any influence of the endogenous E. coli NsrR on the prNZ activity, 25 µM of the NO donor spermine NONOate was added. Expression of the reporter gene was not significantly affected by addition of NONOate, arguing against inhibition of gene activity by endogenous E. coli NsrR, as addition of NO would otherwise have been expected to increase gene activity (Fig. 7B).

In cells transformed with both prNZ and the pecS expression construct (prNZ + pecS), the leaky production of PecS resulted in repression of lacZ expression by ~2-fold compared to cell cultures harboring only the prNZ construct (Fig. 7C). Addition of xanthine to the culture medium restored β-galactosidase activity to that observed in cells not expressing pecS (Fig. 7C). Taken together, these observations indicate that VvPecS represses the nod promoter and that xanthine and/or urate relieves this repression.

Discussion

PecS family proteins are classified by a combination of sequence conservation and structural features as well as being part of a genomic locus that includes the divergently encoded PecM18,19,20,21,22. PecS consistently functions as a repressor of pecS/pecM genes by binding to the pecS-pecM intergenic DNA, and VvPecS conserves this function. PecS paralogs conserve the characteristic structural features, but they are not encoded divergently from a pecM gene, suggesting acquisition of a distinct regulatory function. For example, Streptomyces spp. encode both PecS and TamR, a transcription factor that regulates genes encoding enzymes involved in central metabolism during oxidative stress20,30,31. TamR does not respond to urate, but instead to citrate and structurally related compounds. PecS paralogs (of unknown function) were also detected in a few Vibrio genomes (Table S1). The existence of pecS-pecM duplications in Vibrios is more intriguing, as similar duplications have not been reported in other species. It raises the possibility of distinct responses that have been optimized for the lifestyle of particular species, for example during stress adaptation, either in terms of inducing signal, control of cellular PecS concentration, or control of cellular function by modulation of the PecS regulon32. One possibility is the acquisition of a direct response to oxidants; while VvPecS and closely related PecS proteins have no cysteine residues, the second group of PecS homologs features two conserved cysteines (in the loop between α1 and α2 and immediately preceding β3; Fig. S1). The sequence of the DNA recognition helix (α5; Fig. S1) is also more divergent in the second group of PecS homologs, perhaps allowing recognition of different cognate DNA sites and therefore defining a distinct regulon.

VvPecS binds two specific AT-rich palindromic sites in pecS-pecM intergenic DNA (Fig. 4), with additional flanking sites bound at higher protein concentrations, whereas a single complex was detected in its interaction with nsrR-nod intergenic DNA (Fig. S5). By comparison, D. dadantii PecS protects extended regions in target gene promoters, but no distinct palindromic sequences were identifiable33. In contrast, A. fabrum PecS binds to three palindromic sites, one in the pecS promoter and two overlapping sites in the pecM promoter, and P. atrosepticum PecS protects two discrete sites in pecS-pecM intergenic DNA19,22. Protection of extended DNA regions at higher protein concentrations may ensure more efficient repression of gene activity when PecS is in excess.

A global 3D model of the pecS-pecM intergenic DNA calculated based on the dinucleotide wedge model suggests the existence of significant curvature, a feature that would be expected to promote association with RNA polymerase (reflecting greater promoter strength; Fig. 8)34. Sites for VvPecS are located on either side of the apex; based on the distance between the centers of palindromes (57 bp), a binding mode in which the two first-bound VvPecS dimers are bound on opposite faces of the helix is predicted.

Figure 8
figure 8

Gene regulation by VvPecS. A. Predicted curvature of iSM DNA calculated based on the dinucleotide wedge model using https://www.lfd.uci.edu/~gohlke/dnacurve/. The distance between centers of palindromes predicts binding of VvPecS (magenta) to opposite faces of the duplex. Palindromic binding sites for PecS in magenta. Translational starts identified in blue and with an open arrow. B. Predicted global conformation of iNR DNA with VvPecS site in magenta and predicted NsrR sites in orange; the PecS and NsrR sites overlap by 4 bp. A site that resembles the E. coli NsrR consensus binding site (AANATGCATTT) overlaps the predicted V. vulnificus NsrR site in the nod promoter29.

In addition to sites in pecS-pecM intergenic DNA, VvPecS binds to a conserved palindromic site between nsrR and nod genes, but with lower affinity. The lower affinity binding implies that a greater cellular concentration of PecS would be required for repression. Consistent with this inference, repression of pecS promoter activity is more efficient than repression of the nod promoter (Figs 6 and 7). In vivo, elevated levels of PecS would be expected in the wake of a burst of PecS ligand, allowing maximal expression of pecS. Since the ligands (urate and xanthine) are naturally occurring metabolites that would be degraded or salvaged, such conditions would then be predicted to lead to excess PecS accumulating on the pecS promoter to ensure efficient repression as well as repression of nsrR/nod expression. A similar site in nsrR-nod intergenic DNA is found in V. parahaemolyticus (another well-known human pathogen causing gastroenteritis following consumption of raw oyster), suggesting that PecS-mediated control of nod gene expression is conserved.

Host cells produce ROS and reactive nitrogen species (RNS) upon infection to kill invading bacteria. While NADPH oxidase is the primary source of ROS, XO can contribute to host defenses by using molecular oxygen to generate O2.−/H2O2 (under normoxia) and using nitrate to generate NO (under hypoxia), in the process generating xanthine and urate. In mollusks, however, only certain species (stenoxic bivalves, which tolerate only a narrow range of oxygen levels) have been reported to exhibit XO activity, with XDH activity being responsible for the accumulation of urate that characterizes hypoxia9,12,13. The significance of these purine metabolites is that they accumulate under stress, either in infected vascular tissues of the human host or during molluscan hypoxia. This accumulation rationalizes why Vibrio spp. would recognize these stress markers as signals to induce expression of genes required to survive the adverse conditions.

VvPecS conserves the amino acids previously identified as required for urate binding and for communicating ligand binding to the DNA recognition helices (Fig. S1). In vitro, addition of ligand to pecS-pecM DNA that was saturated with PecS did not result in complete dissociation of PecS, but retention of a slow-migrating complex corresponding to PecS-saturated DNA (Fig. 5). This could be an artifact of the in vitro condition where high PecS concentration was used. However, if cellular levels of PecS were highly elevated, retention of promoter-bound PecS even in presence of ligand would prevent complete derepression of pecS and ward off further PecS synthesis until cellular PecS levels return to a normal range. Consistent with this interpretation, addition of xanthine to cells expressing PecS significantly increases activity of the pecS promoter, but not to the level of cells devoid of PecS, reflecting residual repression (Fig. 6). While this may in part derive from the degradation or salvage of xanthine that would be expected to occur upon cellular uptake, thereby lowering the effective concentration of ligand, it may also reflect the failure of ligands to disrupt a complex in which pecS promoter DNA is saturated with PecS. An argument in favor of the latter interpretation is that addition of xanthine fully restores nod promoter activity to the level observed in absence of PecS; only a single PecS-DNA complex was observed on nod promoter DNA (Figs S5 and 7).

The reported accumulation of urate during molluscan hypoxia and in infected mammalian tissues identifies situations in which VvPecS ligands would be abundant. Our data also suggest a unique target for VvPecS, namely control of the gene encoding NOD. NsrR from several bacterial species has been shown to regulate the gene encoding the flavohemoglobin nitric oxide dioxygenase (the nod gene is denoted as hmp in many species) and other genes that are involved in detoxification of NO and in repair of nitrosothiol species28,35. NsrR contains an iron-sulfur cluster, which is stable in the presence of oxygen. These [Fe-S] clusters are susceptible to NO, a result of which is derepression of genes under NsrR control.

Despite its toxicity, NO may also serve signaling functions in beneficial interactions. Regulatory networks appear to vary among Vibrio species, with NsrR identified as the primary NO-sensing regulator of hmp (nod) gene activity in V. fischeri, while the V. cholerae hmp gene is thought to be primarily controlled by the activator NorR36. Consistent with this inference, binding sites for NsrR are predicted in several target genes according to RegPrecise37, including in V. fischeri, V. parahaemolyticus, and V. vulnificus, while none are predicted in V. cholerae. Notably, two binding sites for V. vulnificus NsrR are predicted in the nsrR-nod intergenic region, one of which overlaps the PecS site (Fig. 8B). This suggests that binding of NsrR and VvPecS would be mutually exclusive. Repression of nod promoter activity by VvPecS suggests a complex regulatory mechanism in which maximal nod expression is achieved under conditions of NO production as well as absence of PecS binding as a result of either presence of PecS ligand or tight control of pecS expression; since molluscan hypoxia is characterized by urate accumulation as well as the ability of XDH to produce NO, this may be one such scenario.

NO is also part of the initial “oxidative burst” generated by eukaryotic cells as an antimicrobial tactic, and it may react with other compounds to form reactive nitrogen species. Inducible nitric oxide synthase (iNOS) can generate large quantities of NO during the mammalian inflammatory process38, and the bacterial NOD is therefore critical for detoxification of NO36. In the low-oxygen environment of the intestinal tract colonized by Vibrios, NOD can convert NO to nitrate (in an oxygen-requiring process) or to nitrous oxide (anaerobically). This is also an environment in which XO-mediated production of ROS has been shown to result in accumulation of urate14. NO damages the NsrR iron-sulfur cluster, a result of which is derepression of nod, and a simultaneous ligand-binding to VvPecS will ensure maximal nod expression.

In the continued absence of VvPecS ligand, VvPecS would control pecS expression and maintain VvPecS homeostasis, and cellular levels would likely be insufficient for binding to the nod gene promoter, which would remain under control of NsrR. However, when VvPecS ligands accumulate (e.g., during molluscan hypoxia), upregulation of pecS would occur, leading to increased cellular levels of VvPecS. As the VvPecS ligands are metabolized (degraded or salvaged), cellular levels of VvPecS may then be sufficient for repression of nod expression. While mammalian tissues experience ischemic reperfusion injury during recovery from hypoxia due to ROS production by XO, the ability of mollusks to tolerate anoxic to normoxic transitions have been correlated with absence of XO activity12. During prolonged anoxia, NO levels have been reported to decrease and to remain low in some tissues even 12 h after reoxygenation39; in these scenarios, VvPecS-mediated repression of nod may be required to avert depletion of NO.

Material and Methods

Sequence analysis and protein modeling

Amino acid sequences were aligned using MUSCLE40. The phylogenetic tree was generated using Clustal Omega and visualized with iTOL, using E. coli MarR as an outgroup41. A VvPecS model was generated with SwissModel in automated mode using the structure of HucR (2fbk) as template and used to map secondary structure elements in the sequence alignment42.

Cloning and purification of VvPecS

The genomic DNA of V. vulnificus YJ016 (provided by Gregg Pettis, LSU) was used as a template to amplify the gene encoding VvPecS (locus tag BJE04_RS19600; old locus tags VVA0819 and VV_RS19625). Primers S1 and S2 containing NdeI and EcoRI restriction sites were used to amplify the pecS gene (for sequences, see Table S3). The resulting PCR product was cloned into the pET28b expression vector at the NdeI-EcoRI sites and the construct was verified by sequencing.

The verified construct was transformed into E. coli BL21(DE3)pLysS. The cells were grown at 37 °C in Luria Bertani (LB) broth with 50 µg/mL kanamycin until OD600 reached ~0.7. Overexpression of VvPecS was achieved by inducing the culture with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 3 hours at 37 °C. The cells were pelleted by centrifugation and stored at −80 °C. The cell pellets were thawed on ice and ~1 g was resuspended in 1 mL of Resuspension (R) buffer (50 mM sodium phosphate pH 7.0, 200 mM NaCl, 0.15 mM PMSF (phenylmethylsulfonyl fluoride) and 1% (v/v) glycerol). A final concentration of 2 mg mL−1 of lysozyme was added to the cell suspension and cells were lysed on ice for 1 hr with intermittent vortexing and sonication. The lysate was collected by centrifugation at 10,000 × g for 30 min and incubated with nickel beads (Sigma-Aldrich, His-Select® Nickel Affinity Gel) that were pre-washed and equilibrated in R buffer at 4 °C for 1 hr. The beads were collected by centrifugation at low speed and washed twice with 10 volumes of R buffer and once with 10 volumes of R buffer containing 10 mM imidazole. The beads were transferred into a gravity flow column and the protein was eluted with R buffer containing a linear gradient of imidazole ranging from 20 mM to 200 mM. The purified protein eluates were pooled and concentrated using Amicon® Ultra Filters and buffer exchanged with R buffer containing 5% glycerol. The purified protein was stored at −80 °C in aliquots and was verified to be ~95% pure on Coomassie Blue G-250 stained SDS-PAGE gels. The VvPecS protein concentration was calculated based on the absorbance at 280 nm and an extinction coefficient of 15470 cm−1 M−1 (VvPecS contains two tryptophan and three tyrosine residues per monomer).

A glutaraldehyde crosslinking assay was performed by incubating 1 µl of 0.005 and 0.05% glutaraldehyde (GTA) with 2 µl of 33 µM VvPecS in a 5 µl reaction using R buffer for 15 minutes at 25 °C. The reaction was stopped by addition of 5 µl 2X Laemmli buffer without β-mercaptoethanol. The samples were separated on 15% SDS-PAGE gels and visualized by Coomassie Blue G-250 staining.

Size exclusion chromatography

Size exclusion chromatography was performed using 50 mM phosphate buffer, pH 7.5, with 150 mM NaCl and a Superdex 200 10/300 GL (GE Healthcare) column. The elution volumes (Ve) for marker proteins chymotrypsin (25 kDa), ovalbumin (42.7 kDa), and albumin (66 kDa) were used to calculate the distribution coefficient using the equation (Ve − Vo)/(Vt − Vo), with geometric bed volume, Vt and void volume, Vo. The distribution coefficient versus Log10 of Molecular weight of markers was used to extrapolate the molecular weight of VvPecS.

Thermal stability assay

VvPecS (2 µM) was incubated in an assay buffer (50 mM Tris pH 8.0, 50 mM NaCl) with 5X SYPRO Orange (Invitrogen) reference fluorescent dye in the presence or absence of ligands urate, xanthine, or guanosine. Fluorescence emission was measured at a range of temperatures (0 to 94 °C) in 1 °C increments for 45 s in an Applied Biosystems 7500 real-time PCR system. A negative control without protein was included to correct the fluorescence yield. The melting curve obtained was fit to a four-parameter sigmoidal equation using Sigma Plot 9 to calculate the (Tm) melting temperature of VvPecS. Experiments were performed in triplicate and the Tm reported as mean ± SD.

Electrophoretic mobility shift assay (EMSA) and quantification of protein-DNA complexes

The respective intergenic DNA regions iSM and iNR between pecS-pecM (BJE04_RS19600-19605) and nod-nsrR (BJE04_RS14765-RS14760; old locus tags VV3064-3063 and VV_RS14775-14770) genes were amplified using the primers listed in Table S3; for iSM, the template was V. vulnificus YJ016 genomic DNA, and for iNR the template was plasmid pCR2.1 containing the synthesized iNR sequence. The DNA fragments were radiolabeled at their 5′ ends using γ-[32P] ATP and T4 polynucleotide kinase. The protein-DNA binding affinity was determined using EMSA. A 10 µl reaction containing 1 fmol of [32P]-labeled intergenic DNA and increasing concentration of purified VvPecS was incubated at 25 °C for 20 minutes in binding (B) buffer (0.5 M Tris pH 8.0, 100 mM NaCl, 6% (v/v) glycerol, 25 µM EDTA, 0.12% Brij-58 and 50 µg of bovine serum albumin). The reaction mixtures were electrophoresed using 0.5 X Tris-borate-EDTA buffer on 8% polyacrylamide gels (39:1 (w/w) acrylamide: bisacrylamide) at 170 V for 1.5 hr at 25 °C; gels were pre-run for 15 min prior to loading the samples. The gel was dried and exposed to a storage phosphor screen and scanned with a Typhoon 8600.

ImageQuant 5.1 (GE Healthcare) was used for quantification of complex and free DNA; total bound DNA was considered as complex and the region on the gel between complex and free DNA was also considered as complex to account for complex dissociation during electrophoresis. KaleidaGraph 4.0 (Synergy Software) was used for fitting of the data to f = fmax * [PecS]n/(Kd + [PecS]n) where [PecS] is the VvPecS protein concentration, f is fractional saturation, Kd is the apparent equilibrium dissociation constant and n is the Hill coefficient. Kd values are reported as the average ± the standard deviation of at least three replicates.

The specificity of VvPecS binding to the intergenic DNA was assessed by mixing [32P]-labeled iSM and iNR with a constant concentration of VvPecS and increasing concentration of non-specific DNA such as pUC18 and linearized Lambda DNA in B buffer.

The effect of ligands xanthine, urate, guanosine, GMP, hypoxanthine and allantoin on VvPecS DNA binding was determined by incubating the protein with the respective ligand at increasing concentration for 10 minutes in B buffer, followed by a 20 min incubation with DNA. The B buffer contains 0.5 M Tris pH 8.0 to prevent a pH change as the ligands were dissolved in 0.4 N NaOH. Reaction mixtures were electrophoresed and processed as described above. All experiments were performed in triplicate. The concentration of ligand, which inhibited 50% of the complex formation (IC50) was calculated using the equation f = A + B X e−k[L], where f is fractional saturation, k is the decay constant, [L] is ligand concentration, A is the saturation plateau and B is the decay amplitude. The IC50 was converted to inhibition constants (Ki) using a web-based tool (https://botdb-abcc.ncifcrf.gov/toxin/kiConverter.jsp), where Ki = IC50/([DNA]50/Kd + [PecS]0/Kd + 1), [DNA]50 is the concentration of DNA at 50% inhibition and [PecS]0 is the protein concentration at 0% inhibition43.

DNase I footprinting

Forward primer S1 (Table S3) was radiolabeled and used to amplify the 200 bp iSM region for footprinting experiments to determine the sequence to which VvPecS binds. Footprinting reactions containing 500 nM iSM DNA with increasing concentration of VvPecS were incubated at 25 °C for 30 minutes in a binding buffer containing 20 mM Tris (pH 8.0), 50 mM NaCl, 0.06% (v/v) BRIJ58, 20 μg mL−1 BSA, 1.5% (v/v) glycerol 5 mM MgCl2, and 2.5 mM CaCl2. Twenty units of DNaseI was added and the samples were incubated for 30 s. The reaction was terminated by addition of an equal volume of loading dye (90% formamide, 10 mM EDTA, 0.1% bromophenol blue and xylene cyanol, 1 mM NaOH). The A + G ladder was prepared using a standardized protocol by Sambrook and Russell44. Samples were heated at 90 °C for 5 min prior to electrophoresis on an 8% denaturing gel [19:1 (w/w) acrylamide/bis-acrylamide, 8 M urea, and 1 × Tris–borate–EDTA buffer (pH 8.3)]. The gel was pre-run at 1800 V to reach 53 °C. The voltage was then adjusted to run samples at a constant temperature of 48 °C. Finally, the gel was dried at 80 °C under vacuum and exposed to a phosphor-imaging screen. The experiment was performed in triplicate.

In vivo gene regulation

The gene expression analyses were performed using the lacZ reporter gene, expressed in plasmid pACYC184 under control of either the pecS promoter or the nod promoter. The pecS-pecM intergenic fragment flanked by BglII sites was amplified with primers S5 and S6 (Table S3) and V. vulnificus YJ016 genomic DNA as template and cloned into the unique BglII site upstream of lacZ in plasmid pRADZ1; only the orientation in which lacZ is under control of the pecS promoter was obtained. The pecS promoter-lacZ fragment was then subcloned into pACYC184 using NruI and BamHI to generate pACYC-prSZ. A promoter-less version of the pACYC-prSZ was obtained by BglII digestion to generate pACYC-Z. A synthetic construct was purchased in which the nod-nsrR intergenic fragment was flanked by BglII sites in pCR2.1, and the nod-nsrR fragment was subcloned into pACYC-Z at the BglII site to generate pACYC-prNZ; the orientation in which lacZ is under control of the nod promoter was obtained. The plasmid constructs were confirmed by sequencing. For both constructs, only one orientation of the intergenic DNA was obtained, even though this was a non-directional cloning. Since β-galactosidase is toxic to E. coli when exported to the periplasm45, we speculate that the opposite orientations of the insert may have introduced a sequence that was translated and interpreted as a signal sequence.

For analysis of gene regulation, plasmids pACYC-prSZ or pACYC-prNZ and the expression vector pET28b-pecS were co-transformed into E. coli T7 Express (which lacks endogenous β-galactosidase activity; New England BioLabs). Cells carrying the pACYC184 and pET28b plasmids were used as negative control, and cells carrying only pACYC-prSZ or pACYC-prNZ were used as positive control. Cells were grown in LB with chloramphenicol (100 µg mL−1; to select for pACYC184 derivatives) and kanamycin (50 µg mL−1; for pET28b derivatives) at 37 °C to 0.6–0.8 OD600nm with or without IPTG (80 µM) and xanthine (10 mM). Cells expressing lacZ under control of the nod promoter were also treated with 25 µM spermidine NONOate to test for potential interference from E. coli NsrR. The cell processing and measurement of β-galactosidase activity using ONPG (o-nitrophenyl β-D-galactopyranoside) as substrate was performed as described46. The activity (in Miller units) was calculated using the equation 1000 × (A420 − 1.75 × A550)/(t × V × A600], where t is reaction time in minutes and V is volume. The culture set up and expression assays were repeated three times, each in technical triplicates.